Cadrenal Therapeutics (CVKD) Appoints Robert Lisicki to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Cadrenal Therapeutics, Inc., ("Cadrenal" or the "Company") (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage.
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD – Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 72,900 shares, an increase of 9.3% from the June 15th total of 66,700 shares. Currently, 2.5% of the shares of the company are […]
Cadrenal Therapeutics’ (NASDAQ:CVKD – Get Free Report) lock-up period will end on Wednesday, July 19th. Cadrenal Therapeutics had issued 1,400,000 shares in its initial public offering on January 20th. The total size of the offering was $7,000,000 based on an initial share price of $5.00. After the end of Cadrenal Therapeutics’ lock-up period, company insiders […]